Variant report

Variant	rs2377966
Chromosome Location	chr10:50506825-50506826
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:31)
CpG islands
(count:0)
Chromatin interactive
region (count:3)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:31 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	POLR2A	chr10:50506647-50509010	K562	blood:	n/a	n/a
2	MEF2A	chr10:50506698-50507392	K562	blood:	n/a	chr10:50507146-50507157 chr10:50507139-50507160 chr10:50507143-50507158
3	MAX	chr10:50506505-50508917	K562	blood:	n/a	n/a
4	UBTF	chr10:50506546-50509056	K562	blood:	n/a	n/a
5	RCOR1	chr10:50506480-50509331	K562	blood:	n/a	n/a
6	TBP	chr10:50506218-50507728	K562	blood:	n/a	n/a
7	UBTF	chr10:50505840-50509021	K562	blood:	n/a	n/a
8	EP300	chr10:50506285-50508997	K562	blood:	n/a	n/a
9	TBL1XR1	chr10:50506821-50509004	K562	blood:	n/a	n/a
10	CHD2	chr10:50506682-50506848	K562	blood:	n/a	n/a
11	GTF2F1	chr10:50506825-50508897	K562	blood:	n/a	n/a
12	PML	chr10:50506688-50507497	K562	blood:	n/a	n/a
13	POLR2A	chr10:50506692-50508387	K562	blood:	n/a	n/a
14	POLR2A	chr10:50505984-50509599	K562	blood:	n/a	n/a
15	POLR2A	chr10:50506790-50509104	K562	blood:	n/a	n/a
16	MAZ	chr10:50506195-50509256	K562	blood:	n/a	n/a
17	TBL1XR1	chr10:50506482-50509073	K562	blood:	n/a	n/a
18	CEBPB	chr10:50506679-50507248	K562	blood:	n/a	chr10:50506681-50506693
19	E2F6	chr10:50506503-50508957	K562	blood:	n/a	n/a
20	MAX	chr10:50506384-50509079	K562	blood:	n/a	n/a
21	CBX3	chr10:50506670-50509246	K562	blood:	n/a	n/a
22	HEY1	chr10:50506603-50506922	K562	blood:	n/a	n/a
23	E2F6	chr10:50506751-50506927	K562	blood:	n/a	n/a
24	POLR2A	chr10:50506604-50509034	K562	blood:	n/a	n/a
25	JUND	chr10:50506718-50509266	K562	blood:	n/a	chr10:50507930-50507940
26	POLR2A	chr10:50506519-50509075	K562	blood:	n/a	n/a
27	POLR2A	chr10:50506579-50509057	K562	blood:	n/a	n/a
28	MYC	chr10:50506692-50508975	K562	blood:	n/a	n/a
29	MYC	chr10:50506631-50509177	K562	blood:	n/a	n/a
30	TEAD4	chr10:50506571-50509128	K562	blood:	n/a	n/a
31	ZMIZ1	chr10:50506799-50508952	K562	blood:	n/a	n/a

No data

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr10:50384969..50387621-chr10:50504946..50509741,4	K562	blood:
2	chr10:49718293..49721279-chr10:50504590..50507564,3	K562	blood:
3	chr10:50374066..50375952-chr10:50506772..50508302,2	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-DRGX-2	chr10:50506735-50506825	XLOC_008817
2	lnc-DRGX-2	chr10:50506735-50506945	XLOC_008817
3	lnc-DRGX-2	chr10:50506735-50506846	NONHSAT013301
4	lnc-DRGX-2	chr10:50506735-50506938	NR_108038

No data

Variant related genes	Relation type
C10orf71	TF binding region
C10orf71-AS1	TF binding region
ENSG00000248682	Chromatin interaction
ENSG00000204161	Chromatin interaction

Extended variants
information (count: 4 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs7899869	1.00[MEX][hapmap]

Variant overlapped rSNPs/rCNVs (count:3 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv895375	chr10:50306386-51028871	Weak transcription Active TSS Strong transcription Enhancers Flanking Active TSS Bivalent Enhancer Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	33 gene(s)	inside rSNPs	diseases
2	nsv534410	chr10:50317458-50826916	Weak transcription Bivalent Enhancer Enhancers Active TSS Strong transcription Flanking Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	30 gene(s)	inside rSNPs	diseases
3	nsv895376	chr10:50480164-50557211	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA	7 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:43 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:50500600-50507800	Weak transcription	Lung	lung
2	chr10:50501800-50507400	Weak transcription	Spleen	Spleen
3	chr10:50503000-50508200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr10:50503600-50507200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
5	chr10:50504200-50507000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
6	chr10:50504400-50507200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
7	chr10:50504800-50511200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
8	chr10:50505000-50507400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
9	chr10:50505000-50507600	Enhancers	HUES6 Cell Line	embryonic stem cell
10	chr10:50505000-50508000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
11	chr10:50505800-50508000	Flanking Active TSS	Fetal Muscle Trunk	muscle
12	chr10:50505800-50509000	Flanking Active TSS	Fetal Muscle Leg	muscle
13	chr10:50505800-50509600	Flanking Active TSS	K562	blood
14	chr10:50506000-50507400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
15	chr10:50506000-50507400	Enhancers	Fetal Lung	lung
16	chr10:50506000-50507600	Bivalent Enhancer	Placenta	Placenta
17	chr10:50506000-50507800	Enhancers	H1 Cell Line	embryonic stem cell
18	chr10:50506000-50508200	Flanking Active TSS	HSMMtube	muscle
19	chr10:50506200-50507000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
20	chr10:50506200-50507800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr10:50506400-50507000	Flanking Active TSS	Stomach Smooth Muscle	stomach
22	chr10:50506400-50507200	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr10:50506400-50507400	Enhancers	iPS-20b Cell Line	embryonic stem cell
24	chr10:50506400-50507800	Enhancers	Adipose Nuclei	Adipose
25	chr10:50506600-50507200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr10:50506600-50507200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
27	chr10:50506600-50507200	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr10:50506600-50507200	Enhancers	Fetal Kidney	kidney
29	chr10:50506600-50507400	Active TSS	Right Atrium	heart
30	chr10:50506600-50508600	Enhancers	HUES64 Cell Line	embryonic stem cell
31	chr10:50506600-50509200	Enhancers	Primary B cells from peripheral blood	blood
32	chr10:50506600-50509200	Enhancers	Fetal Stomach	stomach
33	chr10:50506800-50507000	Active TSS	HSMM	muscle
34	chr10:50506800-50507200	Enhancers	Duodenum Smooth Muscle	Duodenum
35	chr10:50506800-50507200	Active TSS	Ovary	ovary
36	chr10:50506800-50507400	Active TSS	Left Ventricle	heart
37	chr10:50506800-50507400	Active TSS	Pancreas	Pancrea
38	chr10:50506800-50507400	Active TSS	Right Ventricle	heart
39	chr10:50506800-50507400	Active TSS	Skeletal Muscle Female	skeletal muscle
40	chr10:50506800-50507600	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
41	chr10:50506800-50508000	Active TSS	Fetal Heart	heart
42	chr10:50506800-50508600	Active TSS	Psoas Muscle	Psoas
43	chr10:50506800-50509200	Enhancers	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links